Global Gastroparesis Management Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

13/feb/2018 10:09:43 sai krishna Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Gastroparesis is also called as delayed gastric emptying, is a disorder of stomach that hinder the movement of food from stomach to small intestine. Generally, muscles of the GI tract controlled by vagus nerve, that contract to move the food contents throughout the GI tract. Gastroparesis occur when vagus nerve damaged by illness or the injury which leads to slower movement of food contents from stomach to small intestine. Majority of people with gastroparesis have idiopathic gastroparesis of which cause is unknown. Diabetes is commonly known cause of gastroparesis. Elevated sugar levels in diabetics believed to cause damage of vagus nerve and other causes of gastroparesis include gastric surgery, Parkinson’s diseases, and multiple sclerosis. Gastroparesis generally found in females than males.

Rising prevalence of diabetes and gastroparesis, increasing gastroparesis awareness among healthcare professionals expected to propel market for gastroparesis management market over forecast period. Moreover, rising clinical development candidates for treating gastroparesis is expected to fuel the market revenue for gastroparesis management market. For instance, as of now, there are around six drug candidates in clinical development which acts by different mechanisms and route of administration. However, dearth of specific treatment options, large medical unmet need, and lack of gastroparesis management guidelines expected to hamper the gastroparesis management market over forecast period.

A sample of this report is available upon request @

Gastroparesis Management market has been segmented on the basis of cause, gastroparesis type, intervention type, distribution channel, and region

Based on intervention type, gastroparesis management market segmented as follows:

·        Drugs

o   Prokinetic Agents

o   Antiemetics

o   Botulinum Toxin

·        Surgical Treatment

o   Percutaneous Endoscopic Gastroscopic Kit

o   Gastric Electrical Stimulation Devices

o   Parenteral Nutrition


Based on cause, gastroparesis management market segmented as follows:

·        Idiopathic Gastroparesis

·        Diabetic Gastroparesis

·        Surgery

·        Nervous System Disorders

·        Others

Based on gastroparesis type, gastroparesis management market segmented as follows:

·        Acute Gastroparesis

·        Recurrent gastroparesis

Based on distribution channel, Diabetic Gastroparesis Management market segmented as follows:

·        Hospital Pharmacies

·        Retail Pharmacies

·        Drug Stores

·        E-Commerce

To view TOC of this report is available upon request @  

Players in gastroparesis management market developing newer formulations like oral route of administration to bypass stomach and to produce predictable results. For instance, Evoke Pharma developing intranasal metocloparamide i.e. EVK-001, to treat acute and recurrent gastroparesis. Several interventional drugs for treating gastroparesis are in clinical development. Currently Metocloparamide is the only drug approved for treating gastroparesis by US FDA

.Need more information about this report @ 

Gastroparesis management market has been segmented into five regions Viz. North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America gastroparesis market driven by increasing prevalence of disease and potentially 12-16 Mn patients are believed to suffering from gastroparesis in the region. Asia Pacific market expected to grow at significant rate owing to higher prevalence of diabetes in the region. Asian countries contribute around 60% of the world diabetes population which is expected to drive the market revenue growth. Europe market for gastroparesis management expected to grow at moderate CAGR over forecast period.

Some of the players in the gastroparesis management market include Abbott Laboratories, Salix Pharmaceuticals, Inc., Janssen Global Services, LLC, Medtronic, Kimberly-Clark Corporation, C. R. Bard, Inc., Boston Scientific Corporation, Rhythm Pharmaceuticals, Inc., and Evoke Pharma to name a few.

Get access to full summary @ 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights


Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Toll Free (US): +1-866-598-1553
Website @

blog comments powered by Disqus è un servizio offerto da Factotum Srl